Decision on Public Access to Registered Patent Files - EP 3 689 383

The Court of First Instance of the Unified Patent Court adjudicated on a request made by Ter Meer Steinmeister & Partner, a German law firm, for access to certain pleadings and evidence from ongoing legal proceedings involving EP 3 689 383. The applicant sought access primarily due to interest as a legal advisor to pharmaceutical companies, emphasizing the need to inform clients about potential legal actions related to the patent.

The respondent parties, including Johnson & Johnson and others, opposed the request, arguing that the applicant did not demonstrate a 'direct legitimate interest' necessary for access, as they were not a party to the proceedings or acting on behalf of a client intending to file an opposition.

The case highlighted the UPC procedural rule that generally allows public register access unless confidentiality is warranted. However, no specific decision on granting the request is included in the text provided.

UPC Publication Date:07/23/2026
Summarized:07/24/2026
Type:Application RoP262.1 (b)
Court:Brussels (BE) Local Division
Parties:2SEVENTY BIO, INC. v. (1) JOHNSON & JOHNSON v. (2) JANSSEN BIOTECH, INC. v. (3) JANSSEN PHARMACEUTICALS INC. v. (4) JANSSEN-CILAG INTERNATIONAL NV v. (5) JANSSEN PHARMACEUTICA NV v. (6) JANSSEN-CILAG NV v. (7) JANSSEN BIOLOGICS B.V. v. (8) JANSSEN-CILAG B.V. v. (9) JANSSEN-CILAG GMBH v. (10) JANSSEN-CILAG SAS v. (11) JANSSEN-CILAG SPA v. (12) JANSSEN-CILAG A/S v. (13) JANSSEN-CILAG AKTIEBOLAG v. (14) JANSSEN-CILAG FARMACEUTICA LDA. v. (15) LEGEND BIOTECH CORPORATION v. (16) LEGEND BIOTECH USA INC. v. (17) LEGEND BIOTECH IRELAND LIMITED; AND v. (18) LEGEND BIOTECH BELGIUM BV
Winning Party:Unknown
Counterclaim:Yes
Patent Number:EP 3 689 383
Patent Title:N/A
Grounds for decision:Public access to registerDirect legitimate interest requirement
Remedies